(Q31805904)

4 July 2017

title

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers (English)

1 reference

4 July 2017

1 reference

1 reference

1 reference

Ebert U

1

1 reference

4 July 2017

Grossmann M

2

1 reference

4 July 2017

Oertel R

3

1 reference

4 July 2017

Gramatté T

4

1 reference

4 July 2017

Kirch W

5

1 reference

4 July 2017

language of work or name

1 reference

1 January 2001

1 reference

The Journal of Clinical Pharmacology

4 July 2017

published in

1 reference

4 July 2017

volume

41

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

51-60

1 reference

Human memory and the cholinergic system. A relationship to aging?

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Cholinesterase Inhibition in the Scopolamine Model of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Human flash-VEP and quantitative EEG are independently affected by acute scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Synergistic anticholinergic and antiserotonergic effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

A semiparametric approach to physiological flow models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Kinetics of pharmacologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

The effects of transdermal scopolamine on autonomic nervous activity during sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Pharmacokinetics and oral bioavailability of scopolamine in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Brain cholinergic dysfunction and memory in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Alterations in atropine sites of the brain of rats as a function of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122009836

10.1177/00912700122009836

21 January 2018

Identifiers

DOI

1 reference

4 July 2017

1 reference